Nature Communications (Jun 2021)

Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation

  • Sushila A. Toulmin,
  • Chaitali Bhadiadra,
  • Andrew J. Paris,
  • Jeffrey H. Lin,
  • Jeremy Katzen,
  • Maria C. Basil,
  • Edward E. Morrisey,
  • G. Scott Worthen,
  • Laurence C. Eisenlohr

DOI
https://doi.org/10.1038/s41467-021-23619-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Type II alveolar cells play central roles in multiple aspects of lung biology. Here the authors show that type II alveolar cells also constitutively express MHCII, exhibit limited MHCII antigen presentation capacity, and are a component of the host response to respiratory viral infection.